Cancer Medicines Forum workshop
5 April 2024
Amsterdam, NL (Hybrid Event)
The European Medicines Agency (EMA) and EORTC are co-chairing the Cancer Medicines Forum (CMF), whose goal is to support policy decisions to facilitate treatment optimisation in Europe with a focus on post-licensing questions based on clinically relevant end-points for patients in the healthcare setting.
The CMF will report its observations and preliminary solutions to address treatment optimisation at a hybrid workshop at the EMA under the Auspices of the EU Belgian Presidency.
Date: Friday, 5 April 2024, 1:00-6:00 PM (CEST)
Location: European Medicines Agency, Amsterdam
Registration will close on 1 March 2024 for in-person participation and will remain open until 29 March 2024 for online participation.
Next events
Designing clinical trials for older adults with lung cancer
16 November @ 18:00
38th EORTC-NCI-AACR Symposium
18 November - 20 November
Barcelona, Spain
European Cancer Summit 2026
18 November - 19 November
Brussels, Belgium
EORTC Gynecological Cancer Group Autumn Meeting 2026
19 November - 20 November
Leiden, Netherlands
EORTC Leukemia Autumn Group Meeting 2026
14 December
New Orleans, USA
